Global Glycated Hemoglobin Testing Market 2015-2019
出 版 商：Infinitir Research
出版日期：2015/02/25
頁 數：92頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
About Glycated Hemoglobin Testing
Glycated hemoglobin helps measure the concentration of glucose in the blood of an individual. HbA1c, a specific chemical form of glycated hemoglobin, is used to determine a person's average blood glucose level over a period. It is a standardized test recommended by doctors for the diagnosis of type 2 diabetes or to test the control level of the blood glucose. The testing can be done in a laboratory or at a POC center. Different types of technologies, such as chromatography, immunoassay, capillary electrophoresis, direct enzymatic assay, and micro-optical detection method, are used in HbA1c testing.
TechNavio's analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.22 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of Global Glycated Hemoglobin Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of HbA1c products, including
‧ Laboratory HbA1c testing products
‧ POC HbA1c testing products
Based on technology, the market can be characterized into the following segments:
‧ Chromatography
‧ Immunoassay
‧ Others (Capillary Electrophoresis, Direct Enzymatic Assay, and Micro-optical Detection Method)
TechNavio's report, the Global Glycated Hemoglobin Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Abbott Laboratories
‧ Alere
‧ Danaher
‧ F. Hoffmann-La Roche
Other Prominent Vendors
‧ Arkray
‧ Bayer
‧ Bio-Rad Laboratories
‧ Ceragem Medisys
‧ Chek Diagnostics
‧ Daiichi Biotech
‧ DiaSys Diagnostic Systems
‧ Diazyme Laboratories
‧ EKF Diagnostics
‧ Erba Mannheim
‧ Human Diagnostics
‧ Lite-On Technology
‧ Menarini
‧ Mindray Medical
‧ Randox Laboratories
‧ Sebia
‧ Siemens Healthcare
‧ TaiDoc Technology
‧ Tosoh Bioscience
‧ Trinity Biotech
Market Driver
‧ Increased Incidence of Diabetes
‧ For a full, detailed list, view our report
Market Challenge
‧ Availability of Substitutes
‧ For a full, detailed list, view our report
Market Trend
‧ Adoption of POC HbA1c Testing
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2019 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
Glycated hemoglobin helps measure the concentration of glucose in the blood of an individual. HbA1c, a specific chemical form of glycated hemoglobin, is used to determine a person's average blood glucose level over a period. It is a standardized test recommended by doctors for the diagnosis of type 2 diabetes or to test the control level of the blood glucose. The testing can be done in a laboratory or at a POC center. Different types of technologies, such as chromatography, immunoassay, capillary electrophoresis, direct enzymatic assay, and micro-optical detection method, are used in HbA1c testing.
TechNavio's analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.22 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of Global Glycated Hemoglobin Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of HbA1c products, including
‧ Laboratory HbA1c testing products
‧ POC HbA1c testing products
Based on technology, the market can be characterized into the following segments:
‧ Chromatography
‧ Immunoassay
‧ Others (Capillary Electrophoresis, Direct Enzymatic Assay, and Micro-optical Detection Method)
TechNavio's report, the Global Glycated Hemoglobin Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Abbott Laboratories
‧ Alere
‧ Danaher
‧ F. Hoffmann-La Roche
Other Prominent Vendors
‧ Arkray
‧ Bayer
‧ Bio-Rad Laboratories
‧ Ceragem Medisys
‧ Chek Diagnostics
‧ Daiichi Biotech
‧ DiaSys Diagnostic Systems
‧ Diazyme Laboratories
‧ EKF Diagnostics
‧ Erba Mannheim
‧ Human Diagnostics
‧ Lite-On Technology
‧ Menarini
‧ Mindray Medical
‧ Randox Laboratories
‧ Sebia
‧ Siemens Healthcare
‧ TaiDoc Technology
‧ Tosoh Bioscience
‧ Trinity Biotech
Market Driver
‧ Increased Incidence of Diabetes
‧ For a full, detailed list, view our report
Market Challenge
‧ Availability of Substitutes
‧ For a full, detailed list, view our report
Market Trend
‧ Adoption of POC HbA1c Testing
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2019 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 Diabetes
06.2 HbA1c
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Glycated Hemoglobin Testing Market in US
07.3.1 Market Size and Forecast
07.4 Glycated Hemoglobin Testing Market in Japan
07.4.1 Market Size and Forecast
07.5 Glycated Hemoglobin Testing Market in Germany
07.5.1 Market Size and Forecast
07.6 Five Forces Analysis
08. Market Segmentation by Technology
09. Market Segmentation by Method
09.1 Global Laboratory HbA1c Testing Market
09.1.1 Market Size and Forecast
09.2 Global POC HbA1c Testing Market
09.2.1 Market Size and Forecast
10. Geographical Segmentation
10.1 Glycated Hemoglobin Testing Market in Americas
10.1.1 Market Size and Forecast
10.2 Glycated Hemoglobin Testing Market in EMEA Region
10.2.1 Market Size and Forecast
10.3 Glycated Hemoglobin Testing Market in APAC Region
10.3.1 Market Size and Forecast
11. Key Leading Countries
11.1 US
11.2 Japan
11.3 Germany
12. Market Segmentation by Country
12.1 Global Glycated Hemoglobin Testing Market by Country
12.1.1 Market Overview
12.2 Global HbA1c Chromatography Testing Market by Country
12.2.1 Market Overview
12.3 Global HbA1c Immunoassay Testing Market by Country
12.3.1 Market Overview
12.4 Global POC HbA1c Testing Market by Country
12.4.1 Market Overview
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Vendor Analysis 2014
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Abbott Laboratories
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue
21.1.4 Business Segmentation by Revenue 2011 and 2012
21.1.5 Geographical Segmentation by Revenue
21.1.6 Business Strategy
21.1.7 Key Information
21.1.8 SWOT Analysis
21.2 Alere
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Danaher
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 F. Hoffmann-La Roche
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Geographical Segmentation by Revenue 2013
21.4.5 Business Strategy
21.4.6 Key Information
21.4.7 SWOT Analysis
22. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global Glycated Hemoglobin Testing Market 2014-2019
Exhibit 3: Causes of Diabetes
Exhibit 4: Symptoms of Diabetes
Exhibit 5: Formation of HbA1c
Exhibit 6: Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 7: Glycated Hemoglobin Testing Market in US 2014-2019 (US$ million)
Exhibit 8: Glycated Hemoglobin Testing Market in Japan 2014-2019 (US$ million)
Exhibit 9: Glycated Hemoglobin Testing Market in Germany 2014-2019 (US$ million)
Exhibit 10: Segmentation of Global Glycated Hemoglobin Testing Market by Technology
Exhibit 11: Global Glycated Hemoglobin Testing Market by Technology 2014
Exhibit 12: Segmentation of Global Glycated Hemoglobin Testing Market by Method
Exhibit 13: Global Glycated Hemoglobin Testing Market by Method 2014 and 2019
Exhibit 14: Segmentation of Global Glycated Hemoglobin Testing Market (US$ million) and CAGR 2014 and 2019
Exhibit 15: Global Laboratory HbA1c Testing Market 2014-2019 (US$ million)
Exhibit 16: Global POC HbA1c Testing Market 2014-2019 (US$ million)
Exhibit 17: Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 18: Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019
Exhibit 19: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014 and 2019
Exhibit 20: Segmentation of Global Glycated Hemoglobin Testing Market (US$ million) and CAGR 2014 and 2019
Exhibit 21: Glycated Hemoglobin Testing Market in Americas 2014-2019 (US$ million)
Exhibit 22: Glycated Hemoglobin Testing Market in EMEA Region 2014-2019 (US$ million)
Exhibit 23: Glycated Hemoglobin Testing Market in APAC Region 2014-2019 (US$ million)
Exhibit 24: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 25: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (in percent)
Exhibit 26: Global Glycated Hemoglobin Testing Market by Country 2014
Exhibit 27: Global HbA1c Chromatography Testing Market by Country 2014
Exhibit 28: Global HbA1c Immunoassay Testing Market by Country 2014
Exhibit 29: Global HbA1c POC Testing Market by Country 2014
Exhibit 30: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 31: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 32: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 33: Global Glycated Hemoglobin Testing Market: Business Segmentation by Revenue 2013
Exhibit 34: Global Glycated Hemoglobin Testing Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 35: Global Glycated Hemoglobin Testing Market: Geographical Segmentation by Revenue 2013
Exhibit 36: Danaher: Business Segmentation
Exhibit 37: Danaher: Business Segmentation 2013
Exhibit 38: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 39: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 40: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 41: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 42: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 43: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 Diabetes
06.2 HbA1c
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Glycated Hemoglobin Testing Market in US
07.3.1 Market Size and Forecast
07.4 Glycated Hemoglobin Testing Market in Japan
07.4.1 Market Size and Forecast
07.5 Glycated Hemoglobin Testing Market in Germany
07.5.1 Market Size and Forecast
07.6 Five Forces Analysis
08. Market Segmentation by Technology
09. Market Segmentation by Method
09.1 Global Laboratory HbA1c Testing Market
09.1.1 Market Size and Forecast
09.2 Global POC HbA1c Testing Market
09.2.1 Market Size and Forecast
10. Geographical Segmentation
10.1 Glycated Hemoglobin Testing Market in Americas
10.1.1 Market Size and Forecast
10.2 Glycated Hemoglobin Testing Market in EMEA Region
10.2.1 Market Size and Forecast
10.3 Glycated Hemoglobin Testing Market in APAC Region
10.3.1 Market Size and Forecast
11. Key Leading Countries
11.1 US
11.2 Japan
11.3 Germany
12. Market Segmentation by Country
12.1 Global Glycated Hemoglobin Testing Market by Country
12.1.1 Market Overview
12.2 Global HbA1c Chromatography Testing Market by Country
12.2.1 Market Overview
12.3 Global HbA1c Immunoassay Testing Market by Country
12.3.1 Market Overview
12.4 Global POC HbA1c Testing Market by Country
12.4.1 Market Overview
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Vendor Analysis 2014
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Abbott Laboratories
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue
21.1.4 Business Segmentation by Revenue 2011 and 2012
21.1.5 Geographical Segmentation by Revenue
21.1.6 Business Strategy
21.1.7 Key Information
21.1.8 SWOT Analysis
21.2 Alere
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Danaher
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 F. Hoffmann-La Roche
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Geographical Segmentation by Revenue 2013
21.4.5 Business Strategy
21.4.6 Key Information
21.4.7 SWOT Analysis
22. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global Glycated Hemoglobin Testing Market 2014-2019
Exhibit 3: Causes of Diabetes
Exhibit 4: Symptoms of Diabetes
Exhibit 5: Formation of HbA1c
Exhibit 6: Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 7: Glycated Hemoglobin Testing Market in US 2014-2019 (US$ million)
Exhibit 8: Glycated Hemoglobin Testing Market in Japan 2014-2019 (US$ million)
Exhibit 9: Glycated Hemoglobin Testing Market in Germany 2014-2019 (US$ million)
Exhibit 10: Segmentation of Global Glycated Hemoglobin Testing Market by Technology
Exhibit 11: Global Glycated Hemoglobin Testing Market by Technology 2014
Exhibit 12: Segmentation of Global Glycated Hemoglobin Testing Market by Method
Exhibit 13: Global Glycated Hemoglobin Testing Market by Method 2014 and 2019
Exhibit 14: Segmentation of Global Glycated Hemoglobin Testing Market (US$ million) and CAGR 2014 and 2019
Exhibit 15: Global Laboratory HbA1c Testing Market 2014-2019 (US$ million)
Exhibit 16: Global POC HbA1c Testing Market 2014-2019 (US$ million)
Exhibit 17: Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 18: Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019
Exhibit 19: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014 and 2019
Exhibit 20: Segmentation of Global Glycated Hemoglobin Testing Market (US$ million) and CAGR 2014 and 2019
Exhibit 21: Glycated Hemoglobin Testing Market in Americas 2014-2019 (US$ million)
Exhibit 22: Glycated Hemoglobin Testing Market in EMEA Region 2014-2019 (US$ million)
Exhibit 23: Glycated Hemoglobin Testing Market in APAC Region 2014-2019 (US$ million)
Exhibit 24: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 25: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (in percent)
Exhibit 26: Global Glycated Hemoglobin Testing Market by Country 2014
Exhibit 27: Global HbA1c Chromatography Testing Market by Country 2014
Exhibit 28: Global HbA1c Immunoassay Testing Market by Country 2014
Exhibit 29: Global HbA1c POC Testing Market by Country 2014
Exhibit 30: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 31: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 32: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 33: Global Glycated Hemoglobin Testing Market: Business Segmentation by Revenue 2013
Exhibit 34: Global Glycated Hemoglobin Testing Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 35: Global Glycated Hemoglobin Testing Market: Geographical Segmentation by Revenue 2013
Exhibit 36: Danaher: Business Segmentation
Exhibit 37: Danaher: Business Segmentation 2013
Exhibit 38: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 39: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 40: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 41: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 42: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 43: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
